Opaleye Management’s GeneDx Holdings WGS Stock Holding History

Opaleye Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,328	Closed	-$5.24M	–	55
2021 Q2	$5.24M	Buy	+11,328	New	+$4.86M	0.87%	31

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Opaleye Management's WGS Position: Q3 2021 in Review

Opaleye Management sold out of GeneDx Holdings (WGS) in Q3 2021, closing a stake of 11,328 shares — an estimated $5.24M sold.

Opaleye Management first reported a position in WGS in Q2 2021 and held it in 1 quarter. The position peaked at $5.24M in Q2 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q3 2021.

Opaleye Management reported no remaining GeneDx Holdings position as of Q3 2021 after selling out during the quarter.
Opaleye Management sold 11,328 GeneDx Holdings shares in Q3 2021, an estimated $5.24M.
Opaleye Management first reported a position in GeneDx Holdings in Q2 2021 and held it in 1 quarter.
Opaleye Management's GeneDx Holdings position peaked at $5.24M in Q2 2021.
86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2021.

Based on Opaleye Management's 13F filing for Q3 2021, filed 16 Nov 2021.